IP Verse

Apotex Inc. et al. vs Celgene Corporation

The detailed information for PTAB case with proceeding number IPR2018-00685 filed by Apotex Inc. et al. against Celgene Corporation on Feb 23, 2018. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2018-00685
Filing Date: Feb 23, 2018
Petitioner: Apotex Inc. et al.
Respondent: Celgene Corporation
Status: Institution Denied
Respondent Application Number: 12621502
Respondent Tech Center: 1600
Respondent Patent Number: 8741929
Institution Decision Date: Sep 27, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Decision - Denying Petitioner's Request for Rehearing of Decision Denying Institution of Inter Partes Review - 37 CFR 42.71(d)	Apr 30, 2020	PAPER	BOARD
Petitioners' Request for Rehearing	Oct 29, 2018	PAPER	PETITIONER
Trial Instituted Document	Sep 27, 2018	PAPER	BOARD
Submission of Case Law	Jul 20, 2018	PAPER	PETITIONER
Transcript of Telephonic Hearing before Board on July 18, 2018	Jul 20, 2018	EXHIBIT	PETITIONER
Merck Index	Jun 28, 2018	EXHIBIT	PATENT OWNER
NHL Project	Jun 28, 2018	EXHIBIT	PATENT OWNER
Fisher	Jun 28, 2018	EXHIBIT	PATENT OWNER
Damaj	Jun 28, 2018	EXHIBIT	PATENT OWNER
Pro	Jun 28, 2018	EXHIBIT	PATENT OWNER
Intentionally Left Blank	Jun 28, 2018	EXHIBIT	PATENT OWNER
Manning	Jun 28, 2018	EXHIBIT	PATENT OWNER
Ziakas	Jun 28, 2018	EXHIBIT	PATENT OWNER
Wolkenstein	Jun 28, 2018	EXHIBIT	PATENT OWNER
Miller	Jun 28, 2018	EXHIBIT	PATENT OWNER
Lenz 2004	Jun 28, 2018	EXHIBIT	PATENT OWNER
Foran	Jun 28, 2018	EXHIBIT	PATENT OWNER
Goy	Jun 28, 2018	EXHIBIT	PATENT OWNER
'929 File History Excerpts	Jun 28, 2018	EXHIBIT	PATENT OWNER
Wilson	Jun 28, 2018	EXHIBIT	PATENT OWNER
Kaufmann	Jun 28, 2018	EXHIBIT	PATENT OWNER
Zackheim	Jun 28, 2018	EXHIBIT	PATENT OWNER
Intentionally Left Blank	Jun 28, 2018	EXHIBIT	PATENT OWNER
Nguyen	Jun 28, 2018	EXHIBIT	PATENT OWNER
Treon	Jun 28, 2018	EXHIBIT	PATENT OWNER
Desai	Jun 28, 2018	EXHIBIT	PATENT OWNER
Brown	Jun 28, 2018	EXHIBIT	PATENT OWNER
Scheinfeld	Jun 28, 2018	EXHIBIT	PATENT OWNER
Schuler	Jun 28, 2018	EXHIBIT	PATENT OWNER
Jacobson	Jun 28, 2018	EXHIBIT	PATENT OWNER
Tsimberidou	Jun 28, 2018	EXHIBIT	PATENT OWNER
Kuppers	Jun 28, 2018	EXHIBIT	PATENT OWNER
van Horssen	Jun 28, 2018	EXHIBIT	PATENT OWNER
Anderson	Jun 28, 2018	EXHIBIT	PATENT OWNER
Ruggiero	Jun 28, 2018	EXHIBIT	PATENT OWNER
Revlimid Label (09-2017)	Jun 28, 2018	EXHIBIT	PATENT OWNER
Bergsagel	Jun 28, 2018	EXHIBIT	PATENT OWNER
Schaffer	Jun 28, 2018	EXHIBIT	PATENT OWNER
O'Connor	Jun 28, 2018	EXHIBIT	PATENT OWNER
Maes	Jun 28, 2018	EXHIBIT	PATENT OWNER
Eggermont	Jun 28, 2018	EXHIBIT	PATENT OWNER
Watanabe	Jun 28, 2018	EXHIBIT	PATENT OWNER
Bataille	Jun 28, 2018	EXHIBIT	PATENT OWNER
Van Zaanen	Jun 28, 2018	EXHIBIT	PATENT OWNER
EP1682131	Jun 28, 2018	EXHIBIT	PATENT OWNER
Lenz	Jun 28, 2018	EXHIBIT	PATENT OWNER
Bertoni	Jun 28, 2018	EXHIBIT	PATENT OWNER
Brody	Jun 28, 2018	EXHIBIT	PATENT OWNER
Ketterer	Jun 28, 2018	EXHIBIT	PATENT OWNER
Oinonen	Jun 28, 2018	EXHIBIT	PATENT OWNER
Ghielmini	Jun 28, 2018	EXHIBIT	PATENT OWNER
Hiddeman	Jun 28, 2018	EXHIBIT	PATENT OWNER
Fisher	Jun 28, 2018	EXHIBIT	PATENT OWNER
Witzig	Jun 28, 2018	EXHIBIT	PATENT OWNER
Richardson	Jun 28, 2018	EXHIBIT	PATENT OWNER
Patent Owner Preliminary Response	Jun 28, 2018	PAPER	PATENT OWNER
Notice of Accord Filing Date	Mar 28, 2018	PAPER	BOARD
Patent Owner's Mandatory Notices	Mar 16, 2018	PAPER	PATENT OWNER
Patent Owner's Power of Attorney	Mar 16, 2018	PAPER	PATENT OWNER
Petitioners' Power of Attorney	Feb 23, 2018	PAPER	PETITIONER
U.S. Patent No. 8,741,929	Feb 23, 2018	EXHIBIT	PETITIONER
Drach, J. et al., Treatment of Mantle Cell Lymphoma: Targeting the Microenvironment, Expert Review of Anticancer Therapy	Feb 23, 2018	EXHIBIT	PETITIONER
U.S. Patent Application Publication No. 2004/0029832	Feb 23, 2018	EXHIBIT	PETITIONER
Querfeld, C. et al., Preliminary Results of a Phase II Study of CC-5013 (Lenalidomide, Revlimid¿¿) in Patients with Cutaneous T-Cell Lymphoma	Feb 23, 2018	EXHIBIT	PETITIONER
U.S. Application No. 12/621,502, Response to Office Action dated Dec. 18, 2013	Feb 23, 2018	EXHIBIT	PETITIONER
U.S. Application No. 12/621,502, Declaration of Lei Zhang, M.D. dated Dec. 18, 2013	Feb 23, 2018	EXHIBIT	PETITIONER
Declaration of Michael J. Thirman, M.D.	Feb 23, 2018	EXHIBIT	PETITIONER
Celgene Press Release on June 19, 2006	Feb 23, 2018	EXHIBIT	PETITIONER
Petition for Inter Partes Review	Feb 23, 2018	PAPER	PETITIONER
U.S. Application No. 12/621,502, Notice of Allowance and Fees Due issued Jan. 22, 2014	Feb 23, 2018	EXHIBIT	PETITIONER
Harris, N.L. et al., World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting	Feb 23, 2018	EXHIBIT	PETITIONER
Bartlett, J.B. et al, The evolution of thalidomide and its ImiD derivatives as anticancer agents	Feb 23, 2018	EXHIBIT	PETITIONER
Wiernik, H. et al., Preliminary Results from a Phase II Study of Lenalidomide Monotherapy in Relapsed and/or refractory Aggressive Non-Hodgkins Lymphoma abstract	Feb 23, 2018	EXHIBIT	PETITIONER
Revlimid¿¿ (Lenalidomide) Prescription Label published on December 27, 2005	Feb 23, 2018	EXHIBIT	PETITIONER
Wiernik, P.H. et al., Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin¿¿¿s Lymphoma	Feb 23, 2018	EXHIBIT	PETITIONER
Dreyling, M. et al., Treatment for patients with relapsed and/or refractory mantle cell lymphoma: European-based recommendations	Feb 23, 2018	EXHIBIT	PETITIONER
Goy, A., New Directions in the Treatment of Mantle Cell Lymphoma: An Overview	Feb 23, 2018	EXHIBIT	PETITIONER
Mark J. Cameron and David J. Kelvin, Cytokines, Chemokines and Their Receptors	Feb 23, 2018	EXHIBIT	PETITIONER